ULTRAGENYX PHARMACEUTICAL INC. Investment Income, Interest
ULTRAGENYX PHARMACEUTICAL INC. (RARE) reported Investment Income, Interest of $5.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-05
- ULTRAGENYX PHARMACEUTICAL INC. investment income, interest for the quarter ending 2026-06-30 was $5.00M, a 16.67% decline year-over-year.
- ULTRAGENYX PHARMACEUTICAL INC. investment income, interest for the quarter ending 2026-03-31 was $6.00M, a 14.29% decline year-over-year.
- ULTRAGENYX PHARMACEUTICAL INC. investment income, interest for the quarter ending 2025-12-31 was $6.51M, a 35.17% decline year-over-year.
- ULTRAGENYX PHARMACEUTICAL INC. investment income, interest for the quarter ending 2025-09-30 was $5.86M, a 45.36% decline year-over-year.
- ULTRAGENYX PHARMACEUTICAL INC. investment income, interest for fiscal 2025 was $25.00M, a 32.43% decline from fiscal 2024.
- ULTRAGENYX PHARMACEUTICAL INC. investment income, interest for fiscal 2024 was $37.00M, a 37.04% increase from fiscal 2023.
- ULTRAGENYX PHARMACEUTICAL INC. investment income, interest for fiscal 2023 was $27.00M, a 143.81% increase from fiscal 2022.
- ULTRAGENYX PHARMACEUTICAL INC. investment income, interest for fiscal 2022 was $11.07M, a 474.38% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 3 month as first filed | Investment Income, Interest 6 month | Investment Income, Interest 6 month as first filed | Investment Income, Interest 9 month | Investment Income, Interest 12 month | Investment Income, Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $5.00M 10-Q · filed 2026-08-05 | $11.00M 10-Q · filed 2026-08-05 | $17.51M derived: sum of 3 quarters · filed 2026-08-05 | $23.38M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2026-03-31 | $6.00M 10-Q · filed 2026-05-06 | $12.51M derived: sum of 2 quarters · filed 2026-05-06 | $18.38M derived: sum of 3 quarters · filed 2026-05-06 | $24.38M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-12-31 | $6.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $12.38M derived: sum of 2 quarters · filed 2026-02-18 | $18.38M derived: sum of 3 quarters · filed 2026-08-05 | $25.00M 10-K · filed 2026-02-18 | |||
| 2025-09-30 | $5.86M 10-Q · filed 2025-11-05 | $11.86M derived: sum of 2 quarters · filed 2026-08-05 | $18.49M 10-Q · filed 2025-11-05 | $28.91M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-06-30 | $6.00M 10-Q · filed 2026-08-05 | $5.79M 10-Q · filed 2025-08-06 | $13.00M 10-Q · filed 2026-08-05 | $12.63M 10-Q · filed 2025-08-06 | $23.04M derived: sum of 3 quarters · filed 2026-08-05 | $33.77M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $7.00M 10-Q · filed 2026-05-06 | $6.83M 10-Q · filed 2025-05-07 | $17.04M derived: sum of 2 quarters · filed 2026-05-06 | $27.77M derived: sum of 3 quarters · filed 2026-05-06 | $35.18M derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2024-12-31 | $10.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $20.77M derived: sum of 2 quarters · filed 2026-02-18 | $28.18M derived: sum of 3 quarters · filed 2026-02-18 | $37.00M 10-K · filed 2026-02-18 | $36.51M 10-K · filed 2025-02-19 | ||
| 2024-09-30 | $10.73M 10-Q · filed 2025-11-05 | $18.13M derived: sum of 2 quarters · filed 2025-11-05 | $26.96M 10-Q · filed 2025-11-05 | $35.82M derived: sum of 4 quarters · filed 2026-02-18 | |||
| 2024-06-30 | $7.40M 10-Q · filed 2025-08-06 | $16.23M 10-Q · filed 2025-08-06 | $25.09M derived: sum of 3 quarters · filed 2026-02-18 | $30.97M derived: sum of 4 quarters · filed 2026-02-18 | |||
| 2024-03-31 | $8.82M 10-Q · filed 2025-05-07 | $17.69M derived: sum of 2 quarters · filed 2026-02-18 | $23.57M derived: sum of 3 quarters · filed 2026-02-18 | $29.53M derived: sum of 4 quarters · filed 2026-02-18 | |||
| 2023-12-31 | $8.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $14.75M derived: sum of 2 quarters · filed 2026-02-18 | $20.71M derived: sum of 3 quarters · filed 2026-02-18 | $27.00M 10-K · filed 2026-02-18 | $26.69M 10-K · filed 2024-02-21 | ||
| 2023-09-30 | $5.88M 10-Q · filed 2024-11-06 | $11.85M derived: sum of 2 quarters · filed 2024-11-06 | $18.14M 10-Q · filed 2024-11-06 | $24.33M derived: sum of 4 quarters · filed 2025-02-19 | |||
| 2023-06-30 | $5.96M 10-Q · filed 2024-08-02 | $12.25M 10-Q · filed 2024-08-02 | $18.45M derived: sum of 3 quarters · filed 2025-02-19 | $21.93M derived: sum of 4 quarters · filed 2025-02-19 | |||
| 2023-03-31 | $6.29M 10-Q · filed 2024-05-03 | $12.49M derived: sum of 2 quarters · filed 2025-02-19 | $15.97M derived: sum of 3 quarters · filed 2025-02-19 | $16.87M derived: sum of 4 quarters · filed 2025-02-19 | |||
| 2022-12-31 | $6.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $9.68M derived: sum of 2 quarters · filed 2025-02-19 | $10.58M derived: sum of 3 quarters · filed 2025-02-19 | $11.07M 10-K · filed 2025-02-19 | |||
| 2022-09-30 | $3.48M 10-Q · filed 2023-11-03 | $4.38M derived: sum of 2 quarters · filed 2023-11-03 | $4.88M 10-Q · filed 2023-11-03 | $5.32M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-06-30 | $899.00K 10-Q · filed 2023-08-04 | $1.39M 10-Q · filed 2023-08-04 | $1.83M derived: sum of 3 quarters · filed 2024-02-21 | $2.24M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-03-31 | $494.00K 10-Q · filed 2023-05-05 | $934.00K derived: sum of 2 quarters · filed 2024-02-21 | $1.34M derived: sum of 3 quarters · filed 2024-02-21 | $1.78M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2021-12-31 | $440.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $848.00K derived: sum of 2 quarters · filed 2024-02-21 | $1.29M derived: sum of 3 quarters · filed 2024-02-21 | $1.93M 10-K · filed 2024-02-21 | |||
| 2021-09-30 | $408.00K 10-Q · filed 2022-11-03 | $849.00K derived: sum of 2 quarters · filed 2022-11-03 | $1.49M 10-Q · filed 2022-11-03 | $2.47M derived: sum of 4 quarters · filed 2023-02-17 | |||
| 2021-06-30 | $441.00K 10-Q · filed 2022-07-29 | $1.08M 10-Q · filed 2022-07-29 | $2.06M derived: sum of 3 quarters · filed 2023-02-17 | $3.40M derived: sum of 4 quarters · filed 2023-02-17 | |||
| 2021-03-31 | $639.00K 10-Q · filed 2022-05-06 | $1.62M derived: sum of 2 quarters · filed 2023-02-17 | $2.96M derived: sum of 3 quarters · filed 2023-02-17 | $4.76M derived: sum of 4 quarters · filed 2023-02-17 | |||
| 2020-12-31 | $984.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | $2.32M derived: sum of 2 quarters · filed 2023-02-17 | $4.12M derived: sum of 3 quarters · filed 2023-02-17 | $7.04M 10-K · filed 2023-02-17 | |||
| 2020-09-30 | $1.34M 10-Q · filed 2021-11-03 | $3.13M derived: sum of 2 quarters · filed 2021-11-03 | $6.05M 10-Q · filed 2021-11-03 | $8.82M derived: sum of 4 quarters · filed 2022-02-15 | |||
| 2020-06-30 | $1.80M 10-Q · filed 2021-08-03 | $4.72M 10-Q · filed 2021-08-03 | $7.49M derived: sum of 3 quarters · filed 2022-02-15 | $10.80M derived: sum of 4 quarters · filed 2022-02-15 | |||
| 2020-03-31 | $2.92M 10-Q · filed 2021-05-05 | $5.69M derived: sum of 2 quarters · filed 2022-02-15 | $9.01M derived: sum of 3 quarters · filed 2022-02-15 | $13.07M derived: sum of 4 quarters · filed 2022-02-15 | |||
| 2019-12-31 | $2.77M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $6.09M derived: sum of 2 quarters · filed 2022-02-15 | $10.15M derived: sum of 3 quarters · filed 2022-02-15 | $13.24M 10-K · filed 2022-02-15 | |||
| 2019-09-30 | $3.32M 10-Q · filed 2020-10-27 | $7.38M derived: sum of 2 quarters · filed 2020-10-27 | $10.47M 10-Q · filed 2020-10-27 | $13.10M derived: sum of 4 quarters · filed 2021-02-12 | |||
| 2019-06-30 | $4.06M 10-Q · filed 2020-07-30 | $7.15M 10-Q · filed 2020-07-30 | $9.78M derived: sum of 3 quarters · filed 2021-02-12 | $12.51M derived: sum of 4 quarters · filed 2021-02-12 | |||
| 2019-03-31 | $3.09M 10-Q · filed 2020-05-07 | $5.71M derived: sum of 2 quarters · filed 2021-02-12 | $8.44M derived: sum of 3 quarters · filed 2021-02-12 | $10.89M derived: sum of 4 quarters · filed 2021-02-12 | |||
| 2018-12-31 | $2.63M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $5.36M derived: sum of 2 quarters · filed 2021-02-12 | $7.80M derived: sum of 3 quarters · filed 2021-02-12 | $9.54M 10-K · filed 2021-02-12 | |||
| 2018-09-30 | $2.73M 10-Q · filed 2019-11-06 | $5.18M derived: sum of 2 quarters · filed 2019-11-06 | $6.92M 10-Q · filed 2019-11-06 | $7.64M derived: sum of 4 quarters · filed 2020-02-14 | |||
| 2018-06-30 | $2.45M 10-Q · filed 2019-08-02 | $4.18M 10-Q · filed 2019-08-02 | $4.91M derived: sum of 3 quarters · filed 2020-02-14 | $6.03M derived: sum of 4 quarters · filed 2020-02-14 | |||
| 2018-03-31 | $1.74M 10-Q · filed 2019-05-07 | $2.46M derived: sum of 2 quarters · filed 2020-02-14 | $3.58M derived: sum of 3 quarters · filed 2020-02-14 | $4.73M derived: sum of 4 quarters · filed 2020-02-14 | |||
| 2017-12-31 | $724.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $1.84M derived: sum of 2 quarters · filed 2020-02-14 | $2.99M derived: sum of 3 quarters · filed 2020-02-14 | $4.07M 10-K · filed 2020-02-14 | |||
| 2017-09-30 | $1.12M 10-Q · filed 2018-11-06 | $2.27M derived: sum of 2 quarters · filed 2018-11-06 | $3.35M 10-Q · filed 2018-11-06 | $4.26M derived: sum of 4 quarters · filed 2019-02-20 | |||
| 2017-06-30 | $1.15M 10-Q · filed 2018-08-03 | $2.23M 10-Q · filed 2018-08-03 | $3.15M derived: sum of 3 quarters · filed 2019-02-20 | $4.07M derived: sum of 4 quarters · filed 2019-02-20 | |||
| 2017-03-31 | $1.08M 10-Q · filed 2018-05-08 | $1.99M derived: sum of 2 quarters · filed 2019-02-20 | $2.92M derived: sum of 3 quarters · filed 2019-02-20 | $3.89M derived: sum of 4 quarters · filed 2019-02-20 | |||
| 2016-12-31 | $912.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $1.83M derived: sum of 2 quarters · filed 2019-02-20 | $2.81M derived: sum of 3 quarters · filed 2019-02-20 | $3.79M 10-K · filed 2019-02-20 | |||
| 2016-09-30 | $922.00K 10-Q · filed 2017-11-03 | $1.89M derived: sum of 2 quarters · filed 2017-11-03 | $2.88M 10-Q · filed 2017-11-03 | $3.79M derived: sum of 4 quarters · filed 2018-02-21 | |||
| 2016-06-30 | $971.00K 10-Q · filed 2017-07-28 | $1.96M 10-Q · filed 2017-07-28 | $2.87M derived: sum of 3 quarters · filed 2018-02-21 | $3.55M derived: sum of 4 quarters · filed 2018-02-21 | |||
| 2016-03-31 | $984.00K 10-Q · filed 2017-05-05 | $1.90M derived: sum of 2 quarters · filed 2018-02-21 | $2.58M derived: sum of 3 quarters · filed 2018-02-21 | $3.03M derived: sum of 4 quarters · filed 2018-02-21 | |||
| 2015-12-31 | $918.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $1.59M derived: sum of 2 quarters · filed 2018-02-21 | $2.05M derived: sum of 3 quarters · filed 2018-02-21 | $2.32M 10-K · filed 2018-02-21 | |||
| 2015-09-30 | $673.00K 10-Q · filed 2016-11-08 | $1.13M derived: sum of 2 quarters · filed 2016-11-08 | $1.40M 10-Q · filed 2016-11-08 | $1.60M derived: sum of 4 quarters · filed 2017-02-17 | |||
| 2015-06-30 | $456.00K 10-Q · filed 2016-08-09 | $729.00K 10-Q · filed 2016-08-09 | $924.00K derived: sum of 3 quarters · filed 2017-02-17 | $1.09M derived: sum of 4 quarters · filed 2017-02-17 | |||
| 2015-03-31 | $273.00K 10-Q · filed 2016-05-10 | $468.00K derived: sum of 2 quarters · filed 2017-02-17 | $639.00K derived: sum of 3 quarters · filed 2017-02-17 | $788.00K derived: sum of 4 quarters · filed 2017-02-17 | |||
| 2014-12-31 | $195.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $366.00K derived: sum of 2 quarters · filed 2017-02-17 | $515.00K derived: sum of 3 quarters · filed 2017-02-17 | $608.00K 10-K · filed 2017-02-17 | |||
| 2014-09-30 | $171.00K 10-Q · filed 2015-11-10 | $320.00K derived: sum of 2 quarters · filed 2015-11-10 | $413.00K 10-Q · filed 2015-11-10 | $472.00K derived: sum of 4 quarters · filed 2016-02-26 | |||
| 2014-06-30 | $149.00K 10-Q · filed 2015-08-14 | $242.00K 10-Q · filed 2015-08-14 | $301.00K derived: sum of 3 quarters · filed 2016-02-26 | $369.00K derived: sum of 4 quarters · filed 2016-02-26 | |||
| 2014-03-31 | $93.00K 10-Q · filed 2015-05-12 | $152.00K derived: sum of 2 quarters · filed 2016-02-26 | $220.00K derived: sum of 3 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | $59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $127.00K derived: sum of 2 quarters · filed 2016-02-26 | $216.00K 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | $68.00K 10-Q · filed 2014-11-10 | $157.00K 10-Q · filed 2014-11-10 | |||||
| 2012-12-31 | $1.00K 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |